Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Lois M. Mulligan, John B. Kwok, Catherine S. Healey et al. · Nature · 1993
Cited by 1,966 works. doi:10.1038/363458a0
Authors
- Lois M. Mulligan
- John B. Kwok
- Catherine S. Healey
- Mark J. Elsdon
- Charis Eng
- Emily Gardner
- Donald R. Love
- Sara Mole
- Laura Papi
- Margaret A. Ponder
- Håkan Telenius
- Alan Tunnacliffe
- Bruce A.J. Ponder
References
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185
- p53 mutations in colorectal cancer.
- Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.
- Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
- A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential
- A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
- Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.
- Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10
- Human ret proto-oncogene mapped to chromosome 10q11.2.
- cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.